DUR seeks physician feedback

August 15, 2012

The Iowa Medicaid Drug Utilization Review (DUR) Commission is seeking physician feedback on proposed changes to clinical prior authorization criteria. The proposed changes affect the following:

vemurafenib (Zelboraf^TM)
biologicals for arthritis

Click here (PDF 100KB) for details of the proposed changes. Physicians wishing to provide comments on the proposed changes are asked to contact by September 5, 2012.

Comments Submit a comment

There are no comments here yet.

* Type the characters you see in the picture:
* Your Name:
Enter your e-mail if you would like to be notified of replies to your post. Your e-mail will not be visible to others.
Your Email:
* Your Comment:

Other News

June 17, 2013 DMU Receives Accreditation As CME Provider
June 17, 2013 DHS Changes Course on Medicaid Waiver for Iowa Health and Wellness Plan
June 17, 2013 Join us for a great day of golf at the Physicians Golf Challenge!
June 14, 2013 DUR seeks physician feedback
June 03, 2013 IDPH offers free nicotine replacement patches and gum during June
May 31, 2013 Iowa Supreme Court reverses district court fluoroscopy decision
May 30, 2013 DHS updates plans for Medicaid 1115 Waiver
May 17, 2013 Microcystin poisoning continues reportable disease designation
May 17, 2013 FDA issues new tanning beds regulations
May 17, 2013 June 30 deadline for avoiding 2014 E-Prescribing penalty
May 16, 2013 Groundbreaking liability legislation passed in Georgia
May 09, 2013 IMS seeks applicants for Leadership Scholarships
May 08, 2013 IMS 2013: Shape Your Future!
May 06, 2013 IME releases results of ICD-10 Provider Readiness Survey